An insertion/deletion polymorphism in the α2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events

OBJECTIVES Our aim was to study whether an insertion/deletion (I/D) polymorphism in the alpha (2B)-adrenoceptor gene is associated with the risk for cardiovascular diseases. BACKGROUND alpha (2)-adrenoceptors mediate contraction of vascular smooth muscle and induce coronary vasoconstriction in humans. The alpha (2)-adrenoceptor subtype B mediates vasoconstriction in mice. A variant of the human alpha (2B)-adrenoceptor gene that encodes a D of three residues in an intracellular acidic motif has been shown to confer decreased receptor desensitization. This receptor variant could, therefore, be involved in diseases associated with enhanced vasoconstriction. METHODS This study was part of a prospective population-based study investigating risk factors for cardiovascular diseases in a cohort of middle-aged men from eastern Finland. Nine hundred twelve mon aged 46 to 64 years were followed for an average time of 4.5 years. RESULTS In this study population, 192 men (21%) had the D/D genotype; 256 (28%) had the I/I genotype, and 464 (51%) had a heterozygous genotype. In a Cox model adjusting for other coronary risk factors, men with the D/D genotype had 2.2 times (95% confidence interval: 1.1 to 4.4, p = 0.02) the risk to experience an acute coronary event (n = 15 for D/D, 10 for I/I and 12 for I/D) compared with men carrying either of the other two genotypes. The alpha (2B)-adrenoceptor genotype was not associated with hypertension in this study population. CONCLUSIONS The D/D genotype of the alpha (2B)-adrenoceptor is a novel genetic risk factor for acute coronary events, but not for hypertension. (J Am Coll Cardiol 2001;37:1516-22) (C) 2001 by the American College of Cardiology.